- March 15, 2019
Value Transformation: Observations on the Second Annual Evaluation Report of the Oncology Care Model
- March 11, 2019
Precision White Paper: 6 ways to demonstrate the value of your gene therapy
- March 5, 2019
Designing Gene Therapy Trials for Access: What Payers & Health Systems Want to See
In Payerland, you can’t navigate using theories. You need local knowledge to create a compelling case for your product. Precision for Value has it.
We are a group of former payers, academics, health economists, researchers, data analysts, medical reviewers, and marketing gurus. Together, we harness insights from actual payer experience—then pair them with expert analysis to differentiate your medical innovation across the access and reimbursement continuum. Demonstrating value. Communicating it powerfully. Guiding you past roadblocks and detours to find the most direct route to commercial success.
How Manufacturers Can Use Value Assessments to Their Advantage
HCEI Guidance Should Ease Specialty Drug Management
New FDA HCEI and PIE Guidelines Released: Are You Prepared? Webinar Now Available On-Demand!
Dan RenickPresident, Precision Value & Health
Meet the leading citizens of Payerland
We are residents of Payerland. This territory may seem foreign to others, but as former payers ourselves, we know the essentials that tourists often miss. We look forward to showing you the landmarks, introducing you to expert friends, and making you feel welcome.